Evidence map›Paper›PMID 32454905›Full record

ArticleDisease markers2020

The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.

Chengquan Shen, Jing Liu, Jirong Wang, Xiaokun Yang, Haitao Niu, Yonghua Wang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Disease markers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. T Cells With ActivatedFrontiers in immunology · 2022
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chengquan ShenDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Jing LiuDepartment of Research Management and International Cooperation, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Jirong WangDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Xiaokun YangDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Haitao NiuDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.ORCID https://orcid.org/0000-0002-8362-5828
Yonghua WangDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.ORCID https://orcid.org/0000-0002-8861-1003
Qingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression Regulation, NeoplasticAdultAgedAged, 80 and overAtlases as TopicBiomarkers, TumorB-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleHumansMaleMiddle AgedNeoplasm GradingNeoplasm StagingPrognosisBiomarkers, TumorProtein Tyrosine Phosphatase, Non-Receptor Type 6PTPN6 protein, humanReceptors, Tumor Necrosis Factor, Member 14TNFRSF14 protein, human

Identifiers

PMID32454905
PMCPMC7243021
OpenAlexW3025197026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.